ABSTRACT. The hepatotoxicity of paracetamol in mice of 2, 3, 8-10, 24-26, 32-34, and 52-54 wk of age was determined by lethality data, histopathologic examination of the liver, and appearance of glutamate-pyruvate transaminase and glutamate-oxaloacetate transaminase activities in the plasma over an 8-h exposure period. At a dose of 300 mg/kg, there was evidence of hepatocytic necrosis and transaminase leakage in the 32-to 34-and 52-to 54-wk-old mice, but lethality was only recorded in the oldest age group. At 500 mg/kg, paracetamol produced 30% lethality in 3-wk-old mice and between 50 and 90% lethality in the adult age groups. There was histologic evidence of hepatocytic necrosis at all of these ages and its extent increased with age. Similarly, there were increases in plasma transaminases in each of these age groups. However, in 2-wk-old mice there was no lethality, no hepatocytic necrosis, and no increase in plasma transaminases. The lack of susceptibility of 2-wk-old mice to paracetamol toxicity was not due to immaturity of the cytochrome P-450 enzymes responsible for metabolism of paracetamol to its reactive metabolite (N-acetyl-p-benzoquinone imine). In fact, the activity of this enzyme pathway in 2-wk-old mice was greater than that in adults. The partial clearance of the glutathione-derived metabolites of paracetamol after a nontoxic (50 mg/kg) dose was 80% greater in 2-wk-old mice than in 8-to 10-wk-old mice. Therefore, despite having greater capacity to generate N-acetyl-p-benzoquinone imine, 2-wk-old mice had no hepatotoxic effects from a dose that killed at least 50% of adult mice. Factors that relate to the detoxification of N-acetyl-p-benzoquinone imine in the liver are implicated in the lesser susceptibility of postnatal mice to paracetamol toxicity. (Pediatr Res 29: 496-499,1991) to detoxify this metabolite by conjugation to GSH (2-4), and a number of incompletely understood processes initiated by NAPQI that lead to cell death (5).
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It is generally accepted that children are less susceptible to paracetamol toxicity than are adults (6) . This impression has developed from clinical observations that the incidence of overdose toxicity is less in the young (7) . However, the scientific basis for this has yet to be confirmed.
Our present study is aimed at examining developmental aspects of the susceptibility of mice to paracetamol toxicity. Previous work in this field has been conflicting, with some research indicating that young mice (8) and rats (9) are more susceptible to high doses of paracetamol. However, the majority of findings indicate that during the postnatal period young rats and mice are less susceptible to toxicity (10, II). These latter observations have been attributed to the immaturity of the cytochrome P-450-linked mixed function oxidase enzymes in the postnatal period and the consequent decrease in the rate of activation of paracetamol to NAPQI (10) or to a lack of susceptibility to hepatotoxins in general (12) . We have recently observed that hepatocytes from postnatal mice are less susceptible to the toxic effects of paracetamol when compared with cells from adults (13) . However, this lack of susceptibility in the cells from postnatal mice was not due to the immaturity of the enzymes that activate paracetamol to NAPQI (14) .
Our study examined the toxicity of paracetamol in groups of mice ranging in age from 2 wk to I y. It aimed to determine if there is an age-related difference in susceptibility to high doses of paracetamol and whether differences are related to the rate of paracetamol metabolism.
MATERIALS AND METHODS
Received August 7, 1990 High doses of paracetamol cause liver injury in a variety of animal species and in man as a result of its activation to a highly reactive metabolite (I). The susceptibility of hepatocytes to paracetamol is a complex interplay between paracetamol's rate of activation to the putative toxic metabolite, NAPQI (I), the ability Abbreviations GOT, glutamate-oxaloacetate transaminase GPT, glutamate-pyruvate transaminase GSH, reduced glutathione NAPQI, N-acetyl-p-benzoquinone imine Animals. Male and pregnant female Swiss ARC mice (derived from Charles River CD-I mice; Charles River Laboratories, Wilmington, MA) were obtained from the Animal Resources Center (Murdoch, Western Australia). Male adult animals were housed in community cages in groups no larger than 10. Pregnant females were caged separately. After birth, litters were kept with their dams until weaned. The day of birth was recorded as the first morning of observation. All animals had free access to food (RM II autoclavable rat and mouse cubes; Glenn Forrest Stockfeeders, Perth, Western Australia) and tap water. Male mice were separated from females in each litter at 3 wk of age. All animals were maintained at 24°C in a constant environment with a 12-h light/dark cycle (0600 to 1800 h).
Acute hepatotoxicity in vivo. Groups of mice (2, 3, 8-10, 26-28, 32-34, or 52-54 wk of age) received paracetamol as either a 300-or 500-mg/kg dose (intraperitoneally) in saline between 0800 and 0900 h in a volume of 20 mL/kg. These doses were chosen on the basis of previous experience to be a threshold toxic dose and an LD so dose, respectively, in young adults. Control animals were injected with an equal volume of saline. During the following 8 h, any animal that was considered from OUI 496 experience to be near death (moribund and shallow respiration) was killed by cervical dislocation. This was in accordance with the Institution's Animal Ethics guidelines for this type of experiment. These incidences only occurred after 6 h. A blood sample was taken by syringe from the heart and transferred to heparinized microcentrifuge tube for separation of plasma by centrifugation at 2000 rpm for 5 min. Plasma was then analyzed for activity of GOT (EC 2.6.1.1) and GPT (EC 2.6. I.2), using the method of Bergmeyer and Bernt (IS, 16) adapted for a Roche Centrifugal Analyser (Hoffman-LaRoche, Basel, Switzerland). Mid-lateral sections of the caudate lobe of the liver were also removed and placed in 10% buffered formal saline. After 8 h, surviving mice were killed and blood and tissue samples taken as described above. Liver tissue was fixed for 24 h in 10% formal saline, then embedded in paraffin wax. Sections (5 /lm) were cut from paraffin blocks cooled to 4°C, then mounted on glassslides. Sections were stained with hematoxylin and eosin for histopathologic examination (17) . Hepatic sections were examined under the light microscope for extent of necrosis and other morphologic changes. These examinations were carried out in a single blind manner by one of us (J.M.P.).
Pharmacokinetic studies. Radiolabeled [ 14C-phenyl]-paracetamol was obtained from Amersham International (Little Chalfont, UK) and had a sp act of 19.5 mCi/mmol. Purity of the radiolabel was determined by thin layer chromatography on silica gel G/ UV254plates (Macherey Nagel Co., Duren, Germany) using both ethyl acetate, methanol, water, acetic acid (12:6:1.8:0.2) and nbutanol, water, aqueous ammonia (20:2:1) as solvents. Paracetamol chromatographed to a single spot using both solvent systems. For the drug metabolism studies, approximately 200 /lei of 14C-paracetamol was dissolved in absolute ethanol (10 mL) along with 400 mg unlabeled paracetamol (Sigma Chemical Co., St. Louis, MO). The ethanol was then evaporated under a stream of dry nitrogen, after which the labeled mixture was redissolved in isotonic saline to give a final concentration of 25 mg/ml., For plasma clearance determination, 50 /lei of 14C_ paracetamol was mixed with unlabeled paracetamol and prepared as for the metabolism studies.
To determine plasma clearance, adult (8-to lO-wk-old) and postnatal (2-wk-old) mice were administered 14C-paracetamol (50 mg/kg, intraperitoneally) between 0800 and 0850 h. Paracetamol dose was based on body weight because the liver to body weight ratio was similar in both age groups (data not shown). Groups of four mice per age group were killed at IS, 30,45,60, 120, 180, and 240 min after dose administration and a blood sample taken from the heart into a heparinized tube. Unchanged paracetamol was extracted into ethyl acetate as described previously (18) and measured for radioactivity by liquid scintillation counting using a Packard 1500 Tri-Carb liquid scintillant analyzer (Packard Instrument Co., Downers Grove, IL) and internal standardization.
Drug metabolism studies were also carried out on 2-and 8-to 10-wk-old mice using the same dosing regime. Urine was collected over a subsequent 8-h period in metabolism cages, which were then rinsed with 50 mL methanol to recover any remaining urine. The urine remaining in the bladder was obtained by syringe after light pentobarbital anesthesia. The urine was assayed for the presence of paracetamol metabolites by HPLC (19) . Analysis of metabolite peak areas was done using data acquisition and analysis software (DAPA Scientific Software, Kalamunda, Western Australia). Metabolite peaks were identified by comparison of retention times with those for authentic standards of paracetamol and its glucuronide, sulphate, mercapturate, cysteine, and glutathione conjugates. Paracetamol pharmacokinetics were determined using a one-compartment open model. Fractional clearance of the various paracetamol metabolites and unchanged paracetamol were determined by multiplying total clearance by the fraction of the dose recovered as each metabolite appearing in the urine.
Statistical analysis. Analysis of variance was performed using the statistical application GENSTAT (Laws Agricultural Trust, Rothamsted Experimental Station, Harpenden, UK). If a significant variance ratio was indicated, individual group differences were compared with controls by Dunnett's test (20) . Two sample comparisons were by unpaired t test (two-tailed). Table 1 shows the lethality data from groups of mice receiving either 300 or 500 mg/kg paracetamol. At the 300-mg/kg dose, all postnatal (2-and 3-wk-old) mice survived for 8 h, as did adult mice in the age range 2 to 9 mo. However, there was 30% lethality in 12-mo-old mice. At 500 mg/kg, there were no deaths in 2-wk-old mice. In 3-wk-old animals, there was 30% mortality. In the adult age groups, the lethality was between 50 and 90%.
RESULTS
Centrilobular hepatic necrosis was a feature found in mice 3 wk to 12 mo of age that received the high dose of paracetamol (500 mg/kg), but the number of mice with evidence of necrosis varied with age. The severity of the necrosis in each group increased with age. It was least obvious in young mice (3 wk of age) and most pronounced in old animals (6-12 mo old). No necrosis was present in postnatal 2-wk-old mice. In the oldest animals (12 mo old), even the low dose (300 mg/kg) induced some hepatocytic necrosis. However, in postnatal 2-and 3-wkold animals there was no evidence of necrosis at this dose. All cases of necrosis resulted in focal hemorrhages in the affected areas.
The other morphologic changes (other than necrosis) common to all age groups after paracetamol administration at both doses were centrilobular hepatocytic atrophy, mild hepatocytic vacuolation, mild hepatocytic fatty change, loss of sinusoidal cells, focal peliosis, and sinusoidal congestion. These alterations were more pronounced in mice receiving the higher dose of paracetamol. Changes were most apparent in the central zone of hepatic lobules, all of which were uniformly affected. In mice injected with 500 mg/kg, 60 to 70% of each lobule was morphologically deranged, whereas only 20 to 50% was affected by the lower dose of 300 mg/kg, regardless of age.
Plasma GOT and GPT activities were used as biochemical indicators of hepatic damage. Enzyme activity in plasma taken from mice surviving the 8 h after dose administration was combined with data from animals killed during this period ( Table  2 ). The lower dose of 300 mg/kg paracetamol did not increase either GOT or GPT activities in plasma from postnatal (2-and 3-wk-old) mice or young adult (8-to lO-wk-old) mice. In older adults (6-12 mo old), there were increases in the plasma level of GPT activity. In 2-wk-old mice, there was no increase in GOT or GPT activity after injection of 500 mg/kg paracetamol. However, this dose in the other age groups produced marked elevation of plasma GOT and GPT enzyme levels.
The total body clearance of paracetamol was estimated from the decline in plasma concentration with time (Fig. 1) . The clearance rate in 2-wk-old mice of 991 ± 10 mL/h/kg (mean ± SD) was slightly less than the value of 1093 ± 37 mL/h/kg in 
DISCUSSION
Our study indicates that 2-wk-old mice are remarkably resistant to the hepatotoxic effects of high doses of paracetamol when compared with older age groups. This conclusion is based on three lines of evidence: lethality data, morphologic evidence, and biochemical indices of liver injury.
Of the ages examined in our study, the 1-y-old mice were the most susceptible to the lethal effects of paracetamol. Only at this age did the lower dose of paracetamol (300 rug/kg) cause lethality, hepatic necrosis, and elevation of both transaminase activities. Also, 90% of this age group died at the SOO-mg/kg dose. However, although there was some centrilobular derangement in 2-wk-old mice, there was no evidence of liver necrosis after administration of either the 300-or SOO-mg/kg dose at this age. Also, there was no elevation of plasma transaminase activities in the 2-wk-old mice, and this was consistent with the lethality and morphologic data indicating marked resistance to toxic effects at this age. Necrosis was evident in the livers of mice aged 3 wk and older that received the higher dose of paracetamol. Although the data are insufficient to indicate a clear age-related change in susceptibility in the adult mice, the remaining adult age groups appeared to be intermediate between the postnatal ages and the Ly-old mice, inasmuch as there was no evidence that the lower dose produced marked liver injury. There was also an indication that 3-wk-old mice are intermediate between the 2-wk-old and adult age groups. Lethality was reduced at this age and liver necrosis was less extensive than in adults. These results are consistent with previous studies in mice. Mancini et al. (11) found that the LD so of paracetamol during the postnatal period was greater than that in adult mice. Similarly, Hart and Timbrel! (10) found less necrosis in 3-and 8-d-old mice compared with 3S-d-old mice. Beierschmitt et al. (21) found that 3-mo-old mice were more susceptible to paracetamol hepatotoxicity than 1-and 2-mo-old mice.
A simple explanation for the lack of susceptibility of the 2-wkold mice would be that they lack the enzymes that activate paracetamol to its reactive metabolite. This is certainly not the case. In fact, at 2 wk of age these mice have greater capacity to activate paracetamol to NAPQI than do adults. The fractional clearance rate of the GSH-derived metabolites of paracetamol by this cytochrome P-4S0-mediated pathway at 2 wk was 80% greater than that in 8-to lO-wk-old mice. Thus, 2-wk-old mice have a greater capacity to produce NAPQI, yet are less susceptible to its toxic effects. This result is consistent with our previous findings that hepatocytes from 2-wk-old mice generate NAPQI at a greater rate than those from adults (22) .
Inasmuch as the lack of sensitivity to paracetamol toxicity in 2-wk-old mice does not relate to immaturity of the cytochrome P-4S0 enzyme system, it must be associated with the toxic events initiated by NAPQI formation that ultimately result in irreversible cell damage. It is likely that these toxic processes are quenched by superior defense mechanisms in the postnatal liver cell. It has been shown that the a~ivities of the hepatoprotective enzymes, glutathione peroxidase and glutathione reductase, are markedly higher in the liver of2-wk-old mice than in adults (23) . This may be an important factor because there is evidence supporting a role for oxidative stress in paracetamol toxicity. 11 has been found that inhibition of these enzymes potentiate: paracetamol toxicity both in vivo and in vitro (14, 24) . Therefore the higher level of these hepatoprotective enzymes would protec the liver from oxidative stress induced by paracetamol. A greatei capacity to regenerate GSH may also be a factor in this age related difference in susceptibility. Although the basal rate 0 GSH turnover in 2-wk-old mice is not different from that ir adults (23) , it has been shown that hepatocytes from postnata Age (wk) GOT GPT GOT GPT GOT GPT 2 18 ± 4 5±2 20 ± 3 13 ± 3 31 ± 5 13 ± 4 3 20 ± 7 15 ± 5 29 ± 4 22 ± 8 218 ± 27* 480 ± 62* 8-10 22 ± 3 10 ± 3 39 ± 6 12 ± 3 619 ± 11* 797 ± 11* 24-26 12 ± 2 17 ± 3 31 ± 7 68 ± 12* 426 ± 25* 684 ± 35* 32-34 17±421±5 27 ± 4 121 ± 28* 631 ±49* 826 ± 41* 52-54 13±5 13±6 256±38* 596±52* 845±63* 883 ± 34* adult mice (p < 0.05). Table 3 documents the fractional clearance rates of paracetamol and its major metabolites into urine. Total recovery of the injected dose 8 h after paracetamol administration for adult and 2-wk-old mice was 8S ± 2.7 and 92 ± 1.4%, respectively. Of this, 87 and 91%, respectively, could be accounted for as either paracetamol or one of its metabolites eluting from the HPLC column. The fractional clearance rate of the glucuronide conjugate was greater in the adults, whereas that of the sulfate conjugate was similar. The important finding was that the fractional clearance of the GSH-derived metabolites (mercapturate, cysteine, and GSH) of paracetamol was faster in the 2-wk-old mice (138 mL/h/kg) than in adult mice (76 mL/h/kg). After its formation from paracetamol at low doses, NAPQI reacts with GSH to produce a nontoxic conjugate. This can be further metabolized to either a cysteine or mercapturate conjugate. Therefore, the total of these three conjugates after a nontoxic dose is a measure of the amount of NAPQI formed. Because the fractional clearance of these metabolites is faster in 2-wk-old mice than in adult mice, it indicates that the activation pathway mice have a greater capacity for GSH resynthesis after depletion of the cytosolic GSH pool with diethylmaleate (25) .
The generality of this lack of sensitivity to reactive metabolites during the postnatal period has yet to be fully explored. However, given that postnatal rats have been found to be resistant to paracetamol and bromobenzene (12, 26) , and mice to paracetamol (in our present study), it may be that the postnatal period is characterized by a lack of sensitivity to reactive electrophiles. The relevance of this animal model to changes in paracetamol metabolism during childhood and to the susceptibility ofchildren to the toxic effects of high doses of paracetamol is currently being explored.
